![Zelluna ASA [ZLNA]: Notification of transaction by close associate of primary insider](https://i2.wp.com/ml-eu.globenewswire.com/media/YzE0NTAzYzMtNzcwMS00NWRjLWJhMTAtM2I1ZjkxM2JkZjI0LTEyMjA5NDYtMjAyNS0wNC0wNC1lbg==/tiny/Zelluna-ASA.png?w=150&resize=150,150&ssl=1 "Zelluna ASA [ZLNA]: Notification of transaction by close associate of primary insider")
Replimune Presents Late-Breaking Abstract Featuring Data from IGNYTE Clinical Trial of RP1 Combined with Nivolumab in Anti-PD1 Failed Melanoma at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC 2024)
November 09, 2024 13:00 ET | Source: Replimune Group Inc Oral presentation…
Compass Therapeutics Presents Novel Biomarker Data Related to CTX-471 Clinical Activity at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting
New data showed a correlation between the levels of neural cell adhesion…
OnKure to Present Clinical and Preclinical Data for OKI-219 at the 2024 San Antonio Breast Cancer Symposium
November 01, 2024 17:30 ET | Source: OnKure Therapeutics, Inc. OnKure to…